9
Nov
2027
Messe, Frankfurt
9 - 11 November 2027
stand 120F7

BioCina

About BioCina

BioCina is an end-to-end CDMO with 50+ years of pharmaceutical manufacturing heritage, supporting biologic and small-molecule programs from development and clinical supply through commercial scale. Our drug substance capabilities span microbial fermentation, pDNA, mRNA and LNP encapsulation, with expertise across cell line, process, analytical and formulation development through cGMP manufacturing. Our sterile drug product capabilities include blow-fill-seal, vials, pre-filled syringes and cartridges, with dedicated capabilities for cytotoxic injectables and controlled substances. BioCina supports clients with integrated development, manufacturing and scale-up solutions.

Certifications

Meet us at

  • CPHI Frankfurt 2027

    Messe, Frankfurt
    9 - 11 November 2027
    stand 120F7
  • Country/Region:
    Australia
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Primary activities
Contract Research Organisation
Contact info